Philip Nicholas Rodgers, Director at Oxford BioMedica, holds 20.00K shares in Cambridge Cognition Holdings (Ticker: GB:COG), holds 238.90K shares in Destiny Pharma plc (Ticker: GB:DEST), holds 1.04M shares in Oxford BioMedica (Ticker: OXBDF). Most recently, Philip Nicholas Rodgers Bought ― shares of Cambridge Cognition Holdings on Jan 30, 2024 for an estimated value of 10.49K.